Esquire Financial director awarded 753 restricted shares at $0

Esquire Financial Holdings, Inc. reported that one of its directors acquired 753 shares of common stock on December 10, 2025 at a price of $0, reflecting a grant of restricted stock.

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. reported that one of its directors acquired 753 shares of common stock on December 10, 2025 at a price of $0, reflecting a grant of restricted stock.

These 753 restricted shares vest 100% on December 10, 2026. Following this award, the director beneficially owns 4,436 common shares directly and also holds 9,786 shares indirectly through an LLC II, 6,000 shares indirectly through the director's mother, and 127,531 shares indirectly through an LLC I, including restricted stock scheduled to vest in three equal annual installments beginning in 2026 and 2027.

Insider Trade Summary

Grant/Award: 753 shares

Grant/Award 4 txns

Insider Melohn Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	753	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 4,436 shares (Direct); Common Stock — 9,786 shares (Indirect, By LLC II); Common Stock — 6,000 shares (Indirect, By Mother); Common Stock — 127,531 shares (Indirect, By LLC I)

Footnotes (4)

1. F1. Shares of restricted stock vest 100% on December 10, 2026.
2. F2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
3. F3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
4. F4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Esquire Financial Holdings (ESQ) report on December 10, 2025?

A director of Esquire Financial Holdings, Inc. reported acquiring 753 shares of common stock on December 10, 2025, recorded as an acquisition of restricted stock at a price of $0 per share.

How many ESQ shares were acquired in the latest director stock grant?

The Form 4 shows the director acquired 753 shares of Esquire Financial Holdings common stock, identified in the footnotes as restricted stock.

What are the vesting terms of the new restricted stock award at Esquire Financial Holdings (ESQ)?

The filing states that the 753 shares of restricted stock vest 100% on December 10, 2026.

How many Esquire Financial Holdings (ESQ) shares does the reporting person beneficially own after the transaction?

After the reported transaction, the director beneficially owns 4,436 common shares directly and 9,786 shares indirectly through an LLC II, 6,000 shares indirectly through the director's mother, and 127,531 shares indirectly through an LLC I.

How are some of the Esquire Financial (ESQ) restricted shares scheduled to vest in future years?

The filing explains that certain holdings include restricted stock vesting in three equal annual installments, with schedules commencing on December 19, 2026, December 3, 2027, and December 15, 2027.

Is the reported Esquire Financial (ESQ) transaction a purchase or an award?

The transaction is coded as A (acquisition) at a price of $0 per share and described in the footnotes as shares of restricted stock, indicating an equity award rather than an open-market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/16/2025 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Melohn Joseph

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		A		753(1)	A	$0	4,436(2)(3)(4)	D
Common Stock								9,786	I	By LLC II
Common Stock								6,000	I	By Mother
Common Stock								127,531	I	By LLC I

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of restricted stock vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

	/s/ Eric S. Bader, pursuant to power of attorney	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.